Development of Novel Combination Therapies

Janet Woodcock, Joseph P. Griffin, Rachel E. Behrman

New England Journal of Medicine · 2011 · 247 citations · 1 references

Concepts

Abstract

Successful development of future targeted therapies will require the flexibility to rapidly evaluate combination regimens involving new targeted agents in a single development program. The FDA has therefore developed draft guidance on drug co-development.

References

1